Oncogene addiction in gliomas: Implications for molecular targeted therapy
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oncogene addiction in gliomas: Implications for molecular targeted therapy
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 30, Issue 1, Pages 58
Publisher
Springer Nature
Online
2011-05-19
DOI
10.1186/1756-9966-30-58
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases
- (2011) Wei Xu et al. CANCER CELL
- Targeting the degradation of cyclin D1 will help to eliminate oncogene addiction
- (2011) James T. Lee et al. CELL CYCLE
- Identifying cancer driver genes in tumor genome sequencing studies
- (2010) Ahrim Youn et al. BIOINFORMATICS
- Advances in personalised therapeutics in non-small cell lung cancer: 4q12 amplification, PDGFRA oncogene addiction and sunitinib sensitivity
- (2010) Rebecca A. Burrell et al. CANCER BIOLOGY & THERAPY
- An Integrated Approach to Uncover Drivers of Cancer
- (2010) Uri David Akavia et al. CELL
- Targeting miR-21 in glioma: a small RNA with big potential
- (2010) Lynette M Moore et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- 2-hydroxyglutarate accumulation caused byIDHmutation is involved in the formation of malignant gliomas
- (2010) Yukihiko Sonoda et al. Expert Review of Neurotherapeutics
- MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma
- (2010) Chun-Zhi Zhang et al. Molecular Cancer
- OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma
- (2010) Pedro P. Medina et al. NATURE
- IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas
- (2010) C. Houillier et al. NEUROLOGY
- Induction of oncogene addiction shift to NF-κB by camptothecin in solid tumor cells
- (2009) Tomiteru Togano et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- MicroRNA-34a Inhibits Glioblastoma Growth by Targeting Multiple Oncogenes
- (2009) Y. Li et al. CANCER RESEARCH
- Triptolide abrogates oncogene FIP1L1-PDGFRα addiction and induces apoptosis in hypereosinophilic syndrome
- (2009) Yanli Jin et al. CANCER SCIENCE
- The EGFRvIII variant in glioblastoma multiforme
- (2009) Hui K. Gan et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
- (2009) Lenny Dang et al. NATURE
- IDH1andIDH2Mutations in Gliomas
- (2009) Hai Yan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1
- (2009) S. Zhao et al. SCIENCE
- Analysis of the IDH1 codon 132 mutation in brain tumors
- (2008) Jörg Balss et al. ACTA NEUROPATHOLOGICA
- E2F1 in gliomas: A paradigm of oncogene addiction
- (2008) Marta M. Alonso et al. CANCER LETTERS
- Oncogene Addiction
- (2008) I. B. Weinstein et al. CANCER RESEARCH
- Integrated Genomic and Pharmacological Approaches to Identify Synthetic Lethal Genes as Cancer Therapeutic Targets
- (2008) Shinji Mizuarai et al. CURRENT MOLECULAR MEDICINE
- From oncogene to network addiction: the new frontier of cancer genomics and therapeutics
- (2008) Giovanni Tonon Future Oncology
- Drug development of MET inhibitors: targeting oncogene addiction and expedience
- (2008) Paolo M. Comoglio et al. NATURE REVIEWS DRUG DISCOVERY
- Modeling oncogene addiction using RNA interference
- (2008) S. M. Rothenberg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started